ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
140 hedge funds and large institutions have $411M invested in Achillion Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 35 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
54% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 39
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
140
Holding in Top 10
1
Calls
$6.56M
Puts
$1.56M
Top Buyers
| 1 | +$10M | |
| 2 | +$8.37M | |
| 3 | +$7.57M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$6.61M |
| 5 |
State Street
Boston,
Massachusetts
|
+$6.05M |
Top Sellers
| 1 | -$57.1M | |
| 2 | -$12.1M | |
| 3 | -$8.15M | |
| 4 |
RI
RTW Investments
New York
|
-$7.94M |
| 5 |
PA
Perceptive Advisors
New York
|
-$7.53M |